Design of aromatic inhibitors of influenza virus neuraminidase

Journal of Infectious Diseases

Volumn 176, Issue SUPPL. 1, 1997, Pages

  Luo, Ming ^a   Air, Gillian M ^a   Brouillette, Wayne J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; SIALIDASE INHIBITOR; VIRUS SIALIDASE;

ANALYTIC METHOD; CONFERENCE PAPER; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; INFLUENZA; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 0030849874     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514178     Document Type: Conference Paper

References (18)

1. Hirst GK. The agglutination of red blood cells by allantoic fluid of chick embryos infected with influenza virus. Science 1941;94:22-3.
2. Gottschalk A. The viruses. In: Burnet FM, Stanley WM, eds. The viruses. 1959, New York: Academic Press, 1959:51-61.
3. Blok J, Air GM, Laver WG, et al. Studies on the size, chemical composition, and partial sequence of the neuraminidase (NA) from type A influenza viruses show that the N-terminal region of the NA is not processed and serves to anchor the NA in the viral membrane. Virology 1982;119:109-21.
4. Air GM, Laver WG. The neuraminidase of influenza virus. Proteins: Struct Funct Genet 1989;6:341-56.
5. Palese P, Schulman JL. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetyl-neuraminic acid (FANA). Virology 1974;59:490-8.
6. Liu C, Air GM. Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 1993;193:1-5.
7. Doyle PM. Combinatorial chemistry in the discovery and development of drugs. J Chem Tech Biotech 1995;64:317-24.
8. Burmeister WP, Daniels RS, Dayan S, Gagnon J, Cusack S, Ruigrok RW. Sequence and crystallization of influenza virus B/Beijing/1/87 neuraminidase. Virology 1991;180:266-72.
9. Janakiraman MN, White CL, Laver WG, Air GM, Luo M. Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8E resolution: implications for the catalytic mechanism. Biochemistry 1994;33:8172-9.
10. Goodford PJ. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 1985;28:849-57.
11. Miranker A, Karplus M. Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins: Struct Funct Genet 1991;11:29-34.
12. Chong AK, Andrew, KJ, Pegg MS, Taylor MR, von Itzstein M. Evidence for a sialosyl cation transition-state complex in the reaction of sialidase from influenza virus. Eur J Biochem 1992;207:335-43.
13. Meindl P, Bodo G, Palese P, Schulman J, Tuppy H. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 1974;58:457-63.
14. von Itzstein M, Wu WY, Kok GB, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993;363:418-23.
15. Crennell SJ, Garman EF, Laver WG, Vimr ER, Taylor GL. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase. Proc Natl Acad Sci USA 1993;90:9852-6.
16. Jedrzejas MJ, Singh S, Brouillette WJ, Laver WG, Air GM, Luo M. Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry 1995;34:3144-51.
17. Singh S, Jedrzejas M, Air GM, Luo M, Laver WG, Brouillette W. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. J Med Chem 1995;38:3217-25.
18. Aymard-Henry M, Coleman MT, Dowdle WR, Laver WG, Schild GC, Webster RG. Influenza neuraminidase and neuraminidase-inhibition test procedures. Bull WHO 1973;48:199-202.